These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat. Böttcher J, Bässmann H, Schüppel R. J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671 [Abstract] [Full Text] [Related]
7. [On the metabolism of antipyrine (phenazone) in man (author's transl)]. Zietz E, Eichelbaum M, Dengler HJ, Spiteller G. Arzneimittelforschung; 1978 Jun; 28(2):315-9. PubMed ID: 580401 [Abstract] [Full Text] [Related]
8. The metabolism of isopropylantipyrine in the rat and man. Tateishi M, Shimizu H. Xenobiotica; 1976 Apr; 6(4):207-15. PubMed ID: 936642 [Abstract] [Full Text] [Related]
9. 3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance. Danhof M, Teunissen MW, Breimer DD. Pharmacology; 1982 Apr; 24(3):181-4. PubMed ID: 7071130 [Abstract] [Full Text] [Related]
11. Metabolism of metronidazole and antipyrine in hepatocytes isolated from mouse and rat. Loft S, Poulsen HE. Xenobiotica; 1990 Feb; 20(2):185-91. PubMed ID: 2333715 [Abstract] [Full Text] [Related]
12. 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man. Bässmann H, Böttcher J, Schüppel R. Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(2):203-5. PubMed ID: 522906 [Abstract] [Full Text] [Related]
13. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats. Shaw PN, Tseti J, Warburton S, Adedoyin A, Houston JB. Drug Metab Dispos; 1986 Nov; 14(2):271-6. PubMed ID: 2870906 [Abstract] [Full Text] [Related]
14. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man. Danhof M, de Groot-van der Vis E, Breimer DD. Pharmacology; 1979 Nov; 18(4):210-23. PubMed ID: 461498 [Abstract] [Full Text] [Related]
15. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains. Buters JT, Reichen J. Biochem Pharmacol; 1990 Aug 15; 40(4):771-7. PubMed ID: 2386545 [Abstract] [Full Text] [Related]
16. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time. Danhof M, van Zuilen A, Boeijinga JK, Breimer DD. Eur J Clin Pharmacol; 1982 Aug 15; 21(5):433-41. PubMed ID: 7075648 [Abstract] [Full Text] [Related]
17. Isolation and purification of three glucuronides of antipyrine. Proposal for an original analytical method for quantitation of sulpho- and glucuroconjugated metabolites. Palette C, Cordonnier P, Tillequin F, Koch M, Advenier C, Pays M. Biomed Chromatogr; 1994 Aug 15; 8(2):77-84. PubMed ID: 8044026 [Abstract] [Full Text] [Related]
18. Application of molecular-secondary-ion mass spectrometry for drug metabolism studies. I. Direct analysis of conjugates by thin-layer chromatography-secondary-ion mass spectrometry. Iwabuchi H, Nakagawa A, Nakamura K. J Chromatogr; 1987 Feb 20; 414(1):139-48. PubMed ID: 3571378 [Abstract] [Full Text] [Related]